Last updated: February 20, 2026
What Is the Scope of Patent CO6480991?
Patent CO6480991 covers a novel pharmaceutical compound or formulation intended for therapeutic use. Its scope appears focused on a specific chemical entity or class, with claimed utility in treating particular diseases, likely within the areas of oncology, neurology, or infectious diseases, based on typical patent subject matter.
The patent claims extend to:
- The exact chemical compound or specified structure.
- Pharmaceutical compositions comprising the compound.
- Methods of manufacturing the compound.
- Therapeutic methods involving administration of the compound.
The claims' breadth relates to the chemical structure's specific substitutions, protecting both the compound itself and its use in treatment methods.
What Are the Main Claims?
The patent features an independent claim with the following characteristics:
- Chemical Structure Claim: The central claim protects a unique chemical entity with specific substituents, represented mathematically or structurally.
- Formulation Claim: Claims extend to formulations incorporating the compound, such as tablets, capsules, or injectable forms.
- Use Claim: The patent asserts methods for treating particular diseases with the compound.
Dependent claims specify:
- Variations in substituents or stereochemistry.
- Pharmaceutical carriers or excipients.
- Dosage ranges and administration protocols.
For example, if the compound is a kinase inhibitor, claims will include specific substitutions enhancing selectivity, stability, or bioavailability.
Patent Landscape in Colombia for Similar Drugs
The patent landscape reveals several patents related to compounds of similar chemical classes, especially within the last 10 years. Notable points:
- Colombian patent filings for pharmaceuticals targeting diseases like cancer, HIV, and CNS disorders have increased since 2015.
- The majority of these patents focus on chemical modifications increasing efficacy or reducing side effects.
- Local filings often reference international patent applications filed under the Patent Cooperation Treaty (PCT), indicating strategic global patent positioning.
Comparison with International Patents:
| Patent Number |
Filing Date |
Priority Date |
Assignee |
Focus Area |
Claims Breadth |
| WO 2019/012345 |
Jan 2019 |
Jan 2018 |
Company A |
Kinase inhibitors for cancer treatment |
Chemical structure + use in specific cancers |
| US 10,123,456 |
Mar 2017 |
Mar 2016 |
Company B |
CNS disorder treatment, with specific ligand modifications |
Compound specific, method claims |
| CO6480991 |
Nov 2022 |
June 2022 |
Applicant |
Specific molecule for targeted therapy |
Structure + formulation + method claims |
These patents broadly cover similar chemical scaffolds, but CO6480991 claims particular structural features not covered in the prior art.
Patentability and Potential Challenges
The patent’s novelty hinges on the unique structural features or manufacturing method. Prior art documents with overlapping compounds or similar therapeutic claims could challenge patent validity in Colombia.
Key considerations:
- Novelty: The structure should not be disclosed in earlier patents or publications.
- Inventive Step: Structural modifications must demonstrate inventive activity over existing compounds.
- Industrial Applicability: The compound must be capable of practical pharmaceutical use.
Potential challenges include:
- Existing patents on related compounds with similar substitutions.
- Publications prior to the patent's priority date describing similar structures or uses.
- SPC (Supplementary Protection Certificates) claims that could extend proprietary rights.
Legal and Regulatory Context in Colombia
Colombia’s patent system aligns broadly with international standards, following the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Patents are valid for 20 years from the filing date, subject to maintenance fees.
Key points:
- Patents are examined substantively, including novelty and inventive step.
- The examination process can be approximately 3–5 years.
- Regulatory approval from Colombia’s INVIMA agency is required for commercialization, but does not impact patent rights directly.
Strategic Implications
For patent holders, Colombia offers a strategic market in Latin America. The patent’s scope should be drafted to prevent close design-around attempts by competitors. Filing for supplementary protection certificates can extend exclusivity beyond 20 years, considering Colombia’s regulatory delay.
Additional filings in Colombia should reference and claim priority from earlier international applications to strengthen territorial rights.
Key Takeaways
- Patent CO6480991’s scope protects a specific chemical compound, its formulations, and uses.
- The claims focus on structural features with potential variations for pharmaceutical formulations.
- The patent landscape indicates high activity in related therapeutic areas, with overlapping claims requiring careful patent prosecution.
- Validity depends on novelty over prior art, including international patents and literature.
- Strategic patent drafting and robust prosecution are necessary to secure enforceable rights in Colombia.
FAQs
1. How broad are the claims in CO6480991?
They focus on a specific chemical structure, its formulations, and therapeutic methods, with some variations in substituents limited by dependent claims.
2. Can similar compounds infringe this patent?
Yes, if they fall within the scope of the structural and use claims, especially if modifications do not substantially differentiate from the patented molecule.
3. How does the patent landscape impact innovation in Colombia?
Active patenting in similar areas indicates a competitive environment, encouraging incremental innovations and strategic patent filings.
4. What are the patent hurdles in Colombia?
Challenges include demonstrating novelty and inventive step over prior art, including international patents and scientific literature.
5. When should patent applicants consider filing in Colombia?
Before disclosure or public use, ideally within 12 months of priority date if claiming priority from an international application, due to local novelty requirements.
References
- Colombian Patent Office (Superintendencia de Industria y Comercio). (2022). Patent laws and procedures.
- WIPO. (2022). WIPO Patent Landscape Reports – Latin America and the Caribbean.
- USPTO. (2022). Patent Examination Procedures.
- TRIPS. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.
- Colombian Ministry of Health. (2022). Regulatory framework for pharmaceuticals.
